⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GOSS News
Gossamer Bio, Inc. Common Stock
Shareholders who lost money in Gossamer Bio, Inc (NASDAQ: GOSS) Should Contact Wolf Haldenstein Immediately
globenewswire.com
GOSS
GOSS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Gossamer Bio, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
GOSS
Pomerantz LLP Advises Shareholders of Class Action Filing Involving Gossamer Bio, Inc. – GOSS
accessnewswire.com
GOSS
Interstitial Lung Disease Market to Witness Accelerated Growth at a CAGR of 8.7% During the Forecast Period (2026–2036) Due to the Launch of Emerging Therapies | DelveInsight
globenewswire.com
GOSS
LQDA
AMPH
INSM
GSK
Deadline Approaching: Gossamer Bio, Inc. (GOSS) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
businesswire.com
GOSS
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in Gossamer Bio, Inc. of Class Action Lawsuit and Upcoming Deadlines - GOSS
accessnewswire.com
GOSS
Pomerantz LLP Advises Shareholders of Class Action Involving Gossamer Bio, Inc. – GOSS
accessnewswire.com
GOSS
GOSS STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Gossamer Bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
GOSS
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Gossamer Bio, Inc. of Class Action Lawsuit and Upcoming Deadlines – GOSS
globenewswire.com
GOSS
Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages Gossamer Bio, Inc. (GOSS) Shareholders To Inquire About Securities Fraud Class Action
businesswire.com
GOSS